Please provide your email address to receive an email when new articles are posted on . Vuity, an eye drop for the treatment of presbyopia, is now available, according to a press release from AbbVie. ...

EDOF technology, previously used in intraocular lenses, is now available in contact lenses, offering significant improvements ...

Please provide your email address to receive an email when new articles are posted on . The submission is supported by positive data from the phase 3 BRIO-I and BRIO-II studies. If approved, Brimochol ...

A Prescription Drug User Fee Act target date of January 28, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Brimochol ™ ...

Deseyne ® (vifilcon C) Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia with Extended Depth of Focus (EDOF) Delivers Continuous Vision at All Distances—Redefining Presbyopia Correction ...

The FDA approved aceclidine 1.44% ophthalmic solution (Vizz) for adults with presbyopia, or age-related blurred near vision, maker Lenz Therapeutics announced on Thursday. It marks the first ...

In a significant move to enhance brand visibility and outreach, Lenz Therapeutics has launched its 'Make It Vizzable' campaign, featuring renowned actress and produc ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal ...

BOSTON — The investigational Raindrop transparent hydrogel corneal inlay (ReVision Optics) is consistently effective in the correction of presbyopia, relatively easy to implant, and has high patient ...

Company to host conference call on Tuesday, October 29, 2019 at 5:00 pm ET NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical ...

The FDA approved pilocarpine hydrochloride ophthalmic solution (Qlosi) for adults with presbyopia, according to a statement from Orasis Pharmaceuticals. The approval allows for daily or as-needed use, ...